Stay updated on Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.

Latest updates to the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedAdded a system notice about a lapse in government funding. Updated the revision to v3.4.1; the previous revision v3.4.0 was removed.SummaryDifference0.6%

- Check13 days agoChange DetectedDifference0.8%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry v3.3.4 was added and an older revision v3.3.3 was removed. There are no changes to the core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter updates: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedThe header shows Revision: v3.3.2 instead of v3.2.0, indicating a routine site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoval of the government funding notice banner from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.